SuppreMol suppremol.com


Public lists: Pharma Startups (4740)

SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma receptors (FcgRs), which are recombinant autologous therapeutic proteins with a specific immunoregulatory potential. The company's lead product SM101, a recombinant soluble FcgRIIB is in Phase II clinical development for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythema...Show all

SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma receptors (FcgRs), which are recombinant autologous t...Show all

Company (Acquired)

Phone: +49 (0)89 30 90 50 680

Fax:

Am Klopferspitz 19a

Munich, D-82152
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SuppreMol $40.4M Mar 4, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SuppreMol Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.